STEGLUJAN FDA approval date

The FDA approved STEGLUJAN on 19 Dec 2017.

FDA approval date
19 Dec 2017

Drug identity has not yet been verified against registry records

Also recorded as ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2017-12-19DaySTEGLUJANFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA209805", "applicant_as_listed_by_fda": "MSD SUB MERCK", "brand_names": ["STEGLUJAN"], "active_ingredients": ["ERTUGLIFLOZIN", "SITAGLIPTIN PHOSPHATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20171219", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026